House Appropriators Sound Off During FDA Hearing About Formula, More Consumer Health Issues

Before Agriculture/FDA subcommittee about FY2023 budget, Commissioner Robert Califf says FDA needs more resources to address unlisted fragrances in menstrual products and doesn’t have good regulatory options for hemp and kratom. His formula emergency comments leave members frustrated.

Commissioner Robert Califf fielded questions from House appropriators about more than the Food and Drug Administration’s response to the infant formula shortage during a 19 May hearing on the FDA's fiscal year 2023 budget.

The use of hemp ingredients and kratom in dietary supplements and undisclosed fragrances in menstrual products also were covered in...